Caricamento...
Off-label use of anti-IL-1 drugs in rheumatic diseases
Interleukin-1 (IL-1) plays a key role in the pathogenesis of different rheumatic diseases. There are now several agents available on the market capable of blocking IL-1. The proven effectiveness and excellent safety of these drugs makes them a possible therapeutic option in the treatment of IL-1 dri...
Salvato in:
| Pubblicato in: | Int J Immunopathol Pharmacol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056561/ https://ncbi.nlm.nih.gov/pubmed/33855881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20587384211006584 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|